226 related articles for article (PubMed ID: 30370976)
1. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.
Suzuki T; Yazaki Y; Voors AA; Jones DJL; Chan DCS; Anker SD; Cleland JG; Dickstein K; Filippatos G; Hillege HL; Lang CC; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M; Ng LL
Eur J Heart Fail; 2019 Jul; 21(7):877-886. PubMed ID: 30370976
[TBL] [Abstract][Full Text] [Related]
2. Trimethylamine N-oxide and prognosis in acute heart failure.
Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
[TBL] [Abstract][Full Text] [Related]
4. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
5. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
7. Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium.
Israr MZ; Zhan H; Salzano A; Voors AA; Cleland JG; Anker SD; Metra M; van Veldhuisen DJ; Lang CC; Zannad F; Samani NJ; Ng LL; Suzuki T;
Am Heart J; 2022 Jun; 248():108-119. PubMed ID: 35278373
[TBL] [Abstract][Full Text] [Related]
8. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
11. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
12. Reductions in gut microbiota‑derived metabolite trimethylamine N‑oxide in the circulation may ameliorate myocardial infarction‑induced heart failure in rats, possibly by inhibiting interleukin‑8 secretion.
Li X; Sun Y; Zhang X; Wang J
Mol Med Rep; 2019 Jul; 20(1):779-786. PubMed ID: 31180562
[TBL] [Abstract][Full Text] [Related]
13. Ethnic differences in association of outcomes with trimethylamine N-oxide in acute heart failure patients.
Yazaki Y; Aizawa K; Israr MZ; Negishi K; Salzano A; Saitoh Y; Kimura N; Kono K; Heaney L; Cassambai S; Bernieh D; Lai F; Imai Y; Kario K; Nagai R; Ng LL; Suzuki T
ESC Heart Fail; 2020 Oct; 7(5):2373-2378. PubMed ID: 32598563
[TBL] [Abstract][Full Text] [Related]
14. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
[TBL] [Abstract][Full Text] [Related]
16. Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients.
Hochstrasser SR; Metzger K; Vincent AM; Becker C; Keller AKJ; Beck K; Perrig S; Tisljar K; Sutter R; Schuetz P; Bernasconi L; Neyer P; Marsch S; Hunziker S
Clin Chem Lab Med; 2020 Aug; 59(2):393-402. PubMed ID: 32866111
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials.
Li P; Luo Y; Chen YM
Heart Lung Circ; 2013 Oct; 22(10):852-60. PubMed ID: 23602555
[TBL] [Abstract][Full Text] [Related]
18. Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.
Yuzefpolskaya M; Bohn B; Javaid A; Mondellini GM; Braghieri L; Pinsino A; Onat D; Cagliostro B; Kim A; Takeda K; Naka Y; Farr M; Sayer GT; Uriel N; Nandakumar R; Mohan S; Colombo PC; Demmer RT
Circ Heart Fail; 2021 Jun; 14(6):e007909. PubMed ID: 34129361
[TBL] [Abstract][Full Text] [Related]
19. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
[TBL] [Abstract][Full Text] [Related]
20. Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis.
Yao ME; Liao PD; Zhao XJ; Wang L
BMC Cardiovasc Disord; 2020 Jan; 20(1):7. PubMed ID: 31918665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
